Recently there has been increased interest in the use of rheopheresis in patients with nonexudative age-related macular degeneration (AMD). In part, this is because Canada has approved the use of this treatment for macular degeneration. Unfortunately, the approval was in large part based on the earl
β¦ LIBER β¦
Is it time for the biotech sector to laugh yet?
β Scribed by Drake, Peter; Brown, Gregory
- Book ID
- 109908512
- Publisher
- Springer Science and Business Media LLC
- Year
- 1994
- Tongue
- English
- Weight
- 252 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0733-222X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Rheopheresis for macular degeneration: t
β
Jose S. Pulido; Jeffrey Winters
π
Article
π
2005
π
John Wiley and Sons
π
English
β 38 KB
It is time to update βthe graduateβ
β
Larry E. Gundersen
π
Article
π
2003
π
The American Society for Biochemistry and Molecula
π
English
β 42 KB
## Abstract While leaders of the commercial biotechnology industry are impressed with the numbers and quality of science graduates, they complain that they must invest time to further train them about basic aspects of this highly regulated work environment. The addition of a small number of recomme
It is time for everyone to own the bone
β
Andrew D. Bunta
π
Article
π
2011
π
Springer-Verlag
π
English
β 240 KB
PCI for LMCA stenosisβIs it time to ride
β
Carl L. Tommaso
π
Article
π
2006
π
John Wiley and Sons
π
English
β 34 KB
Is it time to review the screening guide
β
A/Prof James E Elder
π
Article
π
2008
π
John Wiley and Sons
π
English
β 47 KB
π 1 views
Is it time to trial vitamin D supplement
β
John McGrath
π
Article
π
2010
π
John Wiley and Sons
π
English
β 67 KB